AGF Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $83.5M | Buy |
205,857
+9,130
| +5% | +$3.7M | 0.38% | 82 |
|
2025
Q1 | $97.9M | Buy |
196,727
+63,201
| +47% | +$31.4M | 0.52% | 60 |
|
2024
Q4 | $69.5M | Sell |
133,526
-29,704
| -18% | -$15.5M | 0.35% | 89 |
|
2024
Q3 | $101M | Buy |
163,230
+41,007
| +34% | +$25.4M | 0.51% | 62 |
|
2024
Q2 | $67.6M | Sell |
122,223
-50,500
| -29% | -$27.9M | 0.38% | 87 |
|
2024
Q1 | $100M | Sell |
172,723
-111,573
| -39% | -$64.8M | 0.56% | 57 |
|
2023
Q4 | $151M | Buy |
284,296
+39,564
| +16% | +$21M | 0.89% | 29 |
|
2023
Q3 | $124M | Buy |
244,732
+44,516
| +22% | +$22.5M | 0.88% | 28 |
|
2023
Q2 | $104M | Buy |
200,216
+64,950
| +48% | +$33.9M | 0.76% | 42 |
|
2023
Q1 | $78M | Sell |
135,266
-49,436
| -27% | -$28.5M | 0.53% | 63 |
|
2022
Q4 | $102M | Buy |
+184,702
| New | +$102M | 0.74% | 36 |
|